Fintel reports that on June 28, 2024, Macquarie initiated coverage of PACS Group (NYSE:PACS) with a Outperform recommendation.
Analyst Price Forecast Suggests 14.06% Upside
As of June 12, 2024, the average one-year price target for PACS Group is 33.66. The forecasts range from a low of 32.32 to a high of $36.75. The average price target represents an increase of 14.06% from its latest reported closing price of 29.51.
See our leaderboard of companies with the largest price target upside.
The projected annual revenue for PACS Group is 3,805MM, an increase of 14.00%. The projected annual non-GAAP EPS is 1.60.
What are Other Shareholders Doing?
VGHCX - Vanguard Health Care Fund Investor Shares holds 1,836K shares representing 1.20% ownership of the company.
FDVLX - Fidelity Value Fund holds 815K shares representing 0.54% ownership of the company.
FSMVX - Fidelity Mid Cap Value Fund holds 236K shares representing 0.15% ownership of the company.
FSLCX - Fidelity Small Cap Stock Fund holds 112K shares representing 0.07% ownership of the company.
WELLS FARGO MASTER TRUST - Wells Fargo Emerging Growth Portfolio Emerging Growth Portfolio holds 84K shares representing 0.06% ownership of the company.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
